Fitusiran update following EAHAD 2021 Congress
Written by Aaron Dennis, February 23, 2021
During the Congress of the European Association for Haemophilia and Allied Disorders (EAHAD) in early February 2021, Sanofi presented its revised fitusiran dosing regimen proposed to mitigate the risk of vascular thrombosis. There is no change to the bleed management guidelines during fitusiran prophylaxis.
You can read the full statement here: https://news.wfh.org/fitusiran-update-following-eahad-2021-congress